Topical Heparin: A Promising Agent for the Prevention of Tracheal Stenosis in Airway Surgery

Journal of Surgical Research

Volumn 157, Issue 1, 2009, Pages

  Sen, Serdar ^a   Meteoglu, Ibrahim ^a   Ogurlu, Mustafa ^a   Sen, Selda ^a   Derinceoz, Onur Ozgun ^a   Barutca, Sabri ^a  

^a ADNAN MENDERES UNIVERSITY   (Turkey)

Author keywords

airway surgery; heparin; mitomycin C; reimplantation; tracheal stenosis

Indexed keywords

HEPARIN; MITOMYCIN C;

AIRWAY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; FOLLOW UP; GRANULATION TISSUE; HEPARINIZATION; IMPLANT; NONHUMAN; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; PROPHYLAXIS; RABBIT; SCORING SYSTEM; SURGICAL WOUND; TRACHEA STENOSIS; TRACHEA SURGERY; WOUND HEALING;

ANIMALS; DISEASE MODELS, ANIMAL; FIBRINOLYTIC AGENTS; FIBROSIS; GRANULATION TISSUE; HEPARIN; MITOMYCIN; NUCLEIC ACID SYNTHESIS INHIBITORS; POSTOPERATIVE COMPLICATIONS; RABBITS; TRACHEA; TRACHEAL STENOSIS; TRANSPLANTATION, AUTOLOGOUS; WOUND HEALING;

EID: 70349832946     PISSN: 00224804     EISSN: 10958673     Source Type: Journal    
DOI: 10.1016/j.jss.2009.01.028     Document Type: Article

References (40)

1. Perepelitsyn I., and Shapshay S.M. Endoscopic treatment of laryngeal and tracheal stenosis-has mitomycin C improved the outcome?. Otolaryngol Head Neck Surg 131 (2004) 16-20
2. Ubell M.L., Ettema S.L., Toohill R.J., et al. Mitomycin-C application in airway stenosis surgery: Analysis of safety and costs. Otolaryngol Head Neck Surg 134 (2006) 403
3. Dodge-Khatami A., Backer C.L., Holinger L.D., et al. Healing of a free tracheal autograft is enhanced by topical vascular endothelial growth factor in an experimental rabbit model. J Thorac Cardiovasc Surg 122 (2001) 554
4. Cincik H., Güngör A., Cekin E., et al. Effects of topical application of mitomycin-C and 5-fluorouracil on myringotomy in rats. Otol Neurotol 26 (2005) 351
5. Correa A.J., Reinisch L., Sanders D.L., et al. Inhibition of subglottic stenosis with mitomycin-C in the canine model. Ann Otol Rhinol Laryngol 108 (1999) 1053
6. Arbag H., Avunduk M.C., Ozer B., et al. Increased expression of epidermal growth factor receptors in the tracheal epithelia after topical mitomycin-C in rabbits. Auris Nasus Larynx 32 (2005) 65
7. Eliashar R., Eliachar I., Esclamado R., et al. Can topical mitomycin prevent laryngotracheal stenosis?. Laryngoscope 109 (1999) 1594
8. Rahbar R., Shapshay S.M., and Healy G.B. Mitomycin: Effects on laryngeal and tracheal stenosis, benefits, and complications. Ann Otol Rhinol Laryngol 110 (2001) 1
9. Rahbar R., Jones D.T., Nuss R.C., et al. The role of mitomycin in the prevention and treatment of scar formation in the pediatric aerodigestive tract: Friend or foe?. Arch Otolaryngol Head Neck Surg 128 (2002) 401
10. Spector J.E., Werkhaven J.A., Spector N.C., et al. Prevention of anterior glottic restenosis in a canine model with topical mitomycin-C. Ann Otol Rhinol Laryngol 110 (2001) 1007
11. Iñiguez-Cuadra R., San Martín Prieto J., Iñiguez-Cuadra M., et al. Effect of mitomycin in the surgical treatment of tracheal stenosis. Arch Otolaryngol Head Neck Surg 7 (2008) 709
12. Lee A.Y., Rickles F.R., Julian J.A., et al. Randomized comparison of low molecular weight heparin and coumarin derivatives on the survival of patients with cancer and venous thromboembolism. J Clin Oncol 23 (2005) 2123
13. Elsayed E., and Becker R.C. The impact of heparin compounds on cellular inflammatory responses: A construct for future investigation and pharmaceutical development. J Thromb Thrombolysis 15 (2003) 11
14. Bowler S.D., Smith S.M., and Lavercombe P.S. Heparin inhibits the immediate response to antigen in the skin and lungs of allergic subjects. Am Rev Respir Dis 147 (1993) 160
15. Ang Y.S., and Mahmud N. Randomized comparison of unfractionated heparin in severe active inflammatory bowel disease. Ailment Pharmacol Ther 14 (2000) 1015
16. Folwaczny C., Frick H., and Hartman G. Anti-inflammatory properties of unfractionated heparin in patients with highly active ulcerative colitis. AJ Gastroenterol 92 (1997) 5
17. Fries W., Pagiaro E., Canova E., et al. The effect of heparin on trinitrobenzene sulphonic acid-induced colitis in the rat. Aliment Parmacal Ther 12 (1998) 229
18. Oremus M., Hanson M.D., Whitlock R., et al. A systematic review of heparin to treat burn injury. J Burn Care Res 28 (2007) 794
19. Nakanishi R., Kawahara K., Takachi T., et al. Early histopathologic features of tracheal allograft rejection: Study in non-immunosuppressed dogs. Transplant Proc 26 (1994) 3715
20. Roh J.L., Kim D.H., Rha K.S., et al. Benefits and risks of mitomycin use in the traumatized tracheal mucosa. Otolaryngol Head Neck Surg 136 (2007) 459
21. Hueman E.M., and Simpson C.B. Airway complications from topical mitomycin C. Otolaryngol Head Neck Surg 133 (2005) 831
22. Simpson C.B., and James J.C. The efficacy of mitomycin-C in the treatment of laryngotracheal stenosis. Laryngoscope 116 (2006) 1923
23. Frucht-Pery J., Siganos C.S., and Ilsar M. Intraoperative application of topical mitomycin C for pterygium surgery. Ophthalmology 103 (1996) 674
24. Rubinfeld R.S., and Stein R.M. Topical mitomycin-C for pterygia: Is single application appropriate?. Ophthalmic Surg Lasers 28 (1997) 662
25. Chan K.O., Gervais M., Tsaparas Y., et al. Effectiveness of intraoperative mitomycin C in maintaining the patency of a frontal sinusotomy: A preliminary report of a double-blind randomized placebo controlled trial. Am J Rhinol 20 (2006) 295
26. Rahman A., Channa S., Niazi J.H., et al. Dacryocystorhinostomy without intubation with intraoperative mitomycin-C. J Coll Phys Surg Pak 16 (2006) 476
27. Hartnick C.J., Hartley B.E.J., Lacy P.D., et al. Topical mitomycin application after laryngotracheal reconstruction. Arch Otolaryngol Head Neck Surg 127 (2001) 1260
28. Hardillo J., Vanclooster C., and Delaere P.R. An investigation of airway wound healing using a novel in vivo model. Laryngoscope 113 (2003) 237
29. Correa A.J., Reinish L., Sanders D.L., et al. Inhibition of subglottic stenosis with mitomycin-C in the canine model. Ann Otol Rhinol Laryngol 108 (1999) 1053
30. Unal M. The successful management of congenital laryngeal web with endoscopic lysis and topical mitomycin-C. Int J Pediatr Otorhinolaryngol 68 (2004) 231
31. Ward R.F., and April M.M. Mitomycin-C in the treatment of tracheal cicatrix after tracheal reconstruction. Int J Pediatr Otorhinolaryngol 44 (1998) 221
32. Gray S.D., Tritle N., and Li W. The effect of mitomycin on extracellular matrix proteins in a rat wound model. Laryngoscope 113 (2003) 237
33. Cham G., Pan J.C., Lim F., et al. Effects of topical heparin, antivenom, tetracycline and dexamethasone treatment in corneal injury resulting from the venom of the black spitting cobra (Naja sumatrana), in a rabbit model. Clin Toxicol (Phila) 44 (2006) 287
34. Gaffney A., and Gaffney P. Rheumatoid arthritis and heparin. Br J Rheumatol 35 (1996) 808
35. Bowler S.D., Smith S.M., and Lavercombe P.S. Heparin inhibits the immediate response to antigen in the skin and lungs of allergic subjects. Am Rev Respir Dis 147 (1993) 160
36. Fan S.Q., Qin L.Y., Cai J.L., et al. Effect of heparin on production of basic fibroblast growth factor and transforming growth factor-beta1 by human normal skin and hyperplastic scar fibroblasts. J Burn Care Res 28 (2007) 734
37. Saliba Jr. M.J. Heparin in the treatment of burns: A review. Burns 27 (2001) 349
38. Kratz G., Back M., Arnander C., et al. Immobilized heparin accelerates the healing of human wounds in vivo. Scand J Plast Reconstr Surg Hand Surg 32 (1998) 381
39. Górski G., Szopiński P., Michalak J., et al. Liposomal heparin spray: A new formula in adjunctive treatment of superficial venous thrombosis. Angiology 56 (2005) 9
40. Vecchio C., and Frisinghelli A. Topically applied heparins for the treatment of vascular disorders: A comprehensive review. Clin Drug Investig 28 (2008) 603